Let’s get to know polyethylene
glycol (PEG) and its potential
effects on your patients.
Patient safety. Two simple words, but with such weight behind them. Physicians, sonographers, nurses, pharmacists – no matter what your role might be, you care about patient safety.
Have you heard about the FDA concerns regarding polyethylene glycol (PEG) and patient safety? PEG can be found in various consumer and medical products—from body creams and cosmetics to the mRNA COVID-19 vaccines. PEG is even found in some ultrasound enhancing agents (UEAs).1,2
Clinicians are, and should be, monitoring PEG and its effects with a closer lens, as newly recognized risks of hypersensitivity to the agent have come to light.
What exactly does this mean for you and your patients?
GE HealthCare Pharmaceutical Diagnostics has developed a series of articles to answer this question and more. Click the links below to read the articles.
FAQ: Why is polyethylene glycol (PEG) adversely impacting echocardiography patients?
How echo labs can manage the risk of polyethylene glycol (PEG) hypersensitivity
Getting it bright: How ultrasound enhancing agents help inform and transform patient care
Curious to learn more?
Complete the form on the right to download the on-demand webinar recording, What Echo Labs Need to Know About PEG. Watch the recording to learn how sonographers can effectively screen patients for PEG hypersensitivity, how to recognize the allergy-like symptoms of PEG hypersensitivity, and manage them if they occur, and which UEA options are available for patients with known or suspected PEG hypersensitivity.
References
Download Now
GE Healthcare | Privacy Policy | Terms of Use | Contact Us | Unsubscribe
500 W. Monroe Street | Chicago, IL 60661
© 2023 GE HealthCare
GE is a trademark of General Electric Company used under trademark license.
January 2023 JB07972US